| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9092690 | Best Practice & Research Clinical Anaesthesiology | 2005 | 14 Pages |
Abstract
Anaesthetic agents display remarkable neuroprotective potential; here, we describe the evidence supporting its use and highlight areas for future development of the field. In particular the application of isoflurane and/or xenon as inhalational neuroprotectants is advocated and evidence for the neuroprotection provided by barbiturates and suppression of cerebral metabolic rate is discussed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Robert D. (Senior House Officer Anaesthetics), Daqing (Senior Lecturer), Mervyn (Professor),